Shaping the Future of Biotech Trials: An Interview with John Moller, CEO of Novotech
Frost & Sullivan Manufacturing
MAY 12, 2025
In this exclusive conversation, John Moller , CEO of Novotech , shares how the companys Asia-Pacific roots, global expansion strategy, and deep biotech specialization position it to become the CRO of choice for biotech and small to mid-sized pharmaceutical companies worldwide. Morgan, Bio-Asia, and Bio-IT World.
Let's personalize your content